Clinical Trial Update: Effect of Progestin-Induced Withdrawal Bleed on Ovulation Induction Cycles With Clomiphene Citrate [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the effect of progestin-induced withdrawal bleed on ovulation induction cycles using clomiphene citrate has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Polycystic Ovary Syndrome

Drugs mentioned

• CLOMIPHENE CITRATE (CLOMIPHENE CITRTAE)

Snippet

Sponsor: University of British Columbia | Conditions: Polycystic Ovary Syndrome, Infertility | Phase 4 | Status: WITHDRAWN